HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 78 filers reported holding HARPOON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 5.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $109,000 | -45.8% | 13,770 | -5.0% | 0.05% | -42.2% |
| Q2 2021 | $201,000 | -54.8% | 14,488 | -31.8% | 0.08% | -55.9% |
| Q1 2021 | $445,000 | +28.2% | 21,252 | +1.8% | 0.19% | +30.6% |
| Q4 2020 | $347,000 | +16.8% | 20,878 | +19.5% | 0.14% | -7.7% |
| Q3 2020 | $297,000 | -10.0% | 17,478 | -12.0% | 0.16% | 0.0% |
| Q2 2020 | $330,000 | – | 19,858 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |